TY -的A2 Murdaca Giuseppe盟——Chlup r . AU - Doubravova b . AU - Bartek j . AU - Zapletalova j . AU - Krystynik o . AU - Prochazka v . PY - 2013 DA - 2013/12/19 TI -糖尿病控制的有效评估使用个人葡萄糖测定仪(CONTOURLINK、拜耳、德国;马蹄莲,Wellion,奥地利;美国Agamatrix李纳斯)SP - 702427六世- 35 AB -这个试验的目的是评估的准确度和精密度(1)electrochemistry-based葡萄糖测定仪CONTOURLINK,马蹄莲,莱纳斯和(2)使用动态血糖的糖尿病控制配置文件(AGP)治疗有效性的标志。葡萄糖测定仪和COBAS INTEGRA 400 +分析仪使用的一个实验室专业估计P-glucose (PG) 112年门诊病人。有112套12 PG估计进行了分析。在每组,意味着3毛细管PG估计在3葡萄糖测定仪和INTEGRA分析仪分别计算。应用SPSS统计程序,诉15日。意味着INTEGRA PG值从2.7到25.3不等更易与L。之间有着很强的关联性意味着PG INTEGRA与CONTOURLINK,与马蹄莲,和莱纳斯;PG偏离INTEGRA大多是在±15%范围内。 Wilcoxon Signed Rank Test revealed differences between CONTOURLINK-INTEGRA and LINUS-INTEGRA; CALLA-INTEGRA showed no difference. SD INTEGRA = 0.061 mmol/L, SD CONTOURLINK/SD CALLA/SD LINUS were 0.256/0.290/0.286 mmol/L. All patients were trained to perform defined 10-point PG profiles to adapt food, exercise, and insulin doses. The PG differences between all tested glucometers and reference values were in borderline of ISO 15197 but worthy of consideration. AGP are helpful markers of diabetes control. SN - 0278-0240 UR - https://doi.org/10.1155/2013/702427 DO - 10.1155/2013/702427 JF - Disease Markers PB - Hindawi Publishing Corporation KW - ER -